X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2232) 2232
Publication (158) 158
Book Review (12) 12
Book Chapter (11) 11
Magazine Article (4) 4
Newsletter (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1459) 1459
male (1319) 1319
phenethylamines - pharmacology (1047) 1047
humans (899) 899
rats (764) 764
female (682) 682
index medicus (503) 503
phenethylamines - administration & dosage (497) 497
pharmacology & pharmacy (429) 429
adult (311) 311
adenosine - analogs & derivatives (299) 299
dose-response relationship, drug (298) 298
phenethylamines - therapeutic use (295) 295
middle aged (269) 269
adenosine - pharmacology (262) 262
mice (258) 258
phenethylamines - metabolism (252) 252
time factors (237) 237
neurosciences (212) 212
phenethylamines (178) 178
rats, sprague-dawley (172) 172
aged (166) 166
in vitro techniques (149) 149
heart rate - drug effects (146) 146
rats, inbred strains (145) 145
blood pressure - drug effects (139) 139
phenethylamines - adverse effects (132) 132
brain - metabolism (130) 130
administration, oral (123) 123
dogs (121) 121
cardiac & cardiovascular systems (119) 119
motor activity - drug effects (114) 114
rats, wistar (110) 110
adenosine (103) 103
behavior, animal - drug effects (100) 100
dofetilide (100) 100
dopamine (99) 99
research (99) 99
sulfonamides - pharmacology (99) 99
dopamine - metabolism (98) 98
rabbits (97) 97
phenethylamines - pharmacokinetics (96) 96
serotonin - metabolism (95) 95
brain - drug effects (94) 94
sulfonamides - administration & dosage (94) 94
adrenergic beta-agonists - pharmacology (93) 93
phenethylamines - analysis (93) 93
rat (93) 93
adolescent (92) 92
disease models, animal (92) 92
analysis (91) 91
clinical trials as topic (91) 91
electrocardiography (90) 90
monoamine oxidase inhibitors - pharmacology (89) 89
phenethylamines - urine (89) 89
purinergic p1 receptor agonists (89) 89
drug interactions (82) 82
psychiatry (82) 82
monoamine oxidase - metabolism (80) 80
injections, intravenous (79) 79
chemistry, analytical (78) 78
ractopamine (78) 78
anti-arrhythmia agents - therapeutic use (77) 77
selegiline - pharmacology (77) 77
sulfonamides - therapeutic use (77) 77
treatment outcome (77) 77
double-blind method (76) 76
phenethylamines - chemistry (75) 75
anti-arrhythmia agents - administration & dosage (74) 74
drugs (74) 74
atrial fibrillation - drug therapy (73) 73
brain (73) 73
toxicology (72) 72
anti-arrhythmia agents - pharmacology (71) 71
biochemistry & molecular biology (70) 70
swine (70) 70
phenethylamines - blood (68) 68
phenylethylamine (67) 67
adrenergic beta-agonists - administration & dosage (66) 66
norepinephrine - metabolism (66) 66
corpus striatum - metabolism (65) 65
pregnancy (65) 65
receptors (65) 65
drug synergism (64) 64
amphetamine (62) 62
drug therapy, combination (61) 61
kinetics (60) 60
serotonin (60) 60
action potentials - drug effects (59) 59
atrial fibrillation (59) 59
guinea pigs (59) 59
sulfonamides - adverse effects (58) 58
purinergic p1 receptor antagonists (57) 57
metabolism (56) 56
neurons - drug effects (56) 56
physiology (56) 56
placebos (56) 56
selegiline - therapeutic use (56) 56
adenosine - administration & dosage (55) 55
asthma - drug therapy (55) 55
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2074) 2074
German (85) 85
Russian (24) 24
Italian (15) 15
French (12) 12
Spanish (9) 9
Japanese (8) 8
Polish (5) 5
Portuguese (4) 4
Chinese (3) 3
Swedish (3) 3
Danish (2) 2
Norwegian (2) 2
Afrikaans (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2016, Volume 216, Issue 3, pp. 283.e1 - 283.e14
Journal Article
International Journal of COPD, ISSN 1176-9106, 06/2016, Volume 11, Issue 1, pp. 1413 - 1424
Background: Minimizing the risk of disease progression and exacerbations is the key goal of COPD management, as these are well-established indicators of poor... 
Deterioration | UMEC/VI | Airway stability | COPD | MORTALITY | MULTICENTER | EFFICACY | SAFETY | LUNG-FUNCTION | 62.5/25 MCG | OBSTRUCTIVE PULMONARY-DISEASE | airway stability | deterioration | RESPIRATORY SYSTEM | TIOTROPIUM | PHYSICAL-ACTIVITY | BRONCHODILATORS | Spirometry | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Benzyl Alcohols - administration & dosage | Benzyl Alcohols - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Quinuclidines - administration & dosage | Chlorobenzenes - administration & dosage | Forced Expiratory Volume | Clinical Trials, Phase III as Topic | Phenethylamines - administration & dosage | Multicenter Studies as Topic | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Female | Surveys and Questionnaires | Retrospective Studies | Quinuclidines - adverse effects | Pulmonary Disease, Chronic Obstructive - diagnosis | Administration, Inhalation | Treatment Outcome | Lung - physiopathology | Disease Progression | Randomized Controlled Trials as Topic | Disease-Free Survival | Muscarinic Antagonists - administration & dosage | Vital Capacity | Chlorobenzenes - adverse effects | Propylamines - administration & dosage | Phenethylamines - adverse effects | Lung - drug effects | Adrenergic beta-2 Receptor Agonists - administration & dosage | Aged | Health Status | Drug Combinations | Propylamines - adverse effects | Pulmonary Disease, Chronic Obstructive - drug therapy | Prevention | Development and progression | Lung diseases, Obstructive | Analysis | Infection control
Journal Article
Addiction Biology, ISSN 1355-6215, 05/2013, Volume 18, Issue 3, pp. 455 - 466
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2016, Volume 11, Issue 6, p. e0157021
1,2-Diarylethylamines including lanicemine, lefetamine, and remacemide have clinical relevance in a range of therapeutic areas including pain management,... 
PHENCYCLIDINE | MK-801 | NMDA RECEPTOR | SIGMA-RECEPTORS | PREPULSE INHIBITION | CHANNEL COMPLEX | MULTIDISCIPLINARY SCIENCES | RAT HIPPOCAMPUS | ACOUSTIC STARTLE | METHYL-D-ASPARTATE | KETAMINE | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Piperidines - administration & dosage | Pyridines - administration & dosage | Drug Overdose - genetics | Humans | Rats | Analgesics, Opioid - therapeutic use | Receptors, Serotonin - genetics | Ketamine - administration & dosage | Psychotropic Drugs - adverse effects | Phencyclidine - adverse effects | Ketamine - adverse effects | Phenethylamines - administration & dosage | Animals | Drug Overdose - pathology | Piperidines - adverse effects | Analgesics, Opioid - chemistry | Phencyclidine - administration & dosage | Acetamides - administration & dosage | Drugs | Drug abuse | Neurosciences | Sigma receptors | Tablets | Epilepsy | Central nervous system | Antagonists | Glutamic acid receptors | Mental depression | Isomers | Psychotropic drugs | Receptors | Pain | Phencyclidine | Rodents | Opioids | Dopamine transporter | Physiology | Inhibition | Gating | Pharmaceutical sciences | Dopamine | Narcotics | Abuse | Serotonin | Channel gating | Legislation | N-Methyl-D-aspartic acid receptors | Pharmacology | Disease control | Sensorimotor gating | Studies | Histamine | Brain research | Ketamine | Pharmacy | Ligands | Norepinephrine
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 06/2019, Volume 71, Issue 6, pp. 956 - 970
Objectives To investigate the mechanism of neuroprotection rendered via pharmacological postconditioning in cerebral ischaemia–reperfusion‐induced injury in... 
global cerebral ischaemia | istradefylline | LY294002 | PI3K | pharmacological postconditioning | APOPTOSIS | ISCHEMIA/REPERFUSION INJURY | ACTIVATION | ANTIOXIDANTS | BRAIN-INJURY | INVOLVEMENT | PTEN | ADENOSINE RECEPTORS | PATHWAY | PHARMACOLOGY & PHARMACY | CARDIOPROTECTION | Phenethylamines - pharmacology | Purines - pharmacology | Phenanthrenes - administration & dosage | Morpholines - pharmacology | Male | Brain Ischemia - prevention & control | Adenosine - pharmacology | Purines - administration & dosage | Adenosine - administration & dosage | Adenosine A2 Receptor Agonists - administration & dosage | PTEN Phosphohydrolase - antagonists & inhibitors | Phenanthrenes - pharmacology | Phenethylamines - administration & dosage | Animals | Neuroprotective Agents - pharmacology | Reperfusion Injury - prevention & control | Adenosine A2 Receptor Agonists - pharmacology | Time Factors | Adenosine - analogs & derivatives | Mice | Chromones - pharmacology | Neuroprotective Agents - administration & dosage | Proto-Oncogene Proteins c-akt - metabolism | Phosphatidylinositol 3-Kinase - metabolism | Ischemia | Analysis | Occlusion | Neuroprotection | Adenosine | Parameters | AKT protein | Pharmacology | Arteries | Carotid arteries | 1-Phosphatidylinositol 3-kinase | Inhibitors | Reperfusion | Cerebral blood flow | Rodents | Infarction | Carotid artery | PTEN protein | Injuries
Journal Article
Addiction Biology, ISSN 1355-6215, 09/2013, Volume 18, Issue 5, pp. 812 - 825
Journal Article